Vaccine advisers to the Centers for Disease Control and Prevention have scheduled a meeting for April 23 to take up the question of whether Johnson & Johnson’s Janssen coronavirus vaccine causes blood clots and, if so, what to do about it.
The CDC’s Advisory Committee on Immunization Practices met Wednesday without voting on taking any action on news about six cases of a rare type of blood clotting event in people who got the J&J vaccine. They said they needed more information.
The CDC and US Food and Drug Administration say they are seeking information on whether there are more cases, and whether other blood clot types might be associated with vaccination.
The CDC and FDA on Tuesday recommended a pause in giving out J&J vaccines while they gather information and inform clinicians about how to recognize and treat the condition.